RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SIRAVEGNA G
Collezione AOU Città della Salute di Torino

Items : 6

Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should know. in European radiology / Eur Radiol. 2020 Aug;30(8):4496-4503. doi: 10.1007/s00330-020-06700-4. Epub 2020 Mar 19.

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Odisio BC; Veltri A; Bardelli A; Gupta S; Fonio P; Gazzera C; Kopetz S; Yevich SM; Stranieri G; Siravegna G; Calandri M;

Review: Peering through a keyhole: liquid biopsy in primary and metastatic central nervous system tumours. in Neuropathology and applied neurobiology / Neuropathol Appl Neurobiol. 2019 Dec;45(7):655-670. doi: 10.1111/nan.12553. Epub 2019 May 14.

2019
AOU Città della Salute di Torino

Bardelli A; Soffietti R; Rudà R; Siravegna G; Bertero L; Cassoni P;

Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer. in Gut / Gut. 2018 Nov;67(11):1995-2005. doi: 10.1136/gutjnl-2016-313372. Epub 2017 Oct 5.

2018
AOU Città della Salute di Torino

Di Nicolantonio F; Sartore-Bianchi A; Bardelli A; Esteller M; Siena S; Michels KB; Racca P; Grady WM; Truini M; Matullo G; Zavattari P; Vanzati A; Maden S; Bencardino K; Bustreo S; Cancelliere C; Guarrera S; Cristiano C; Oddo D; Binder AM; Falcomatà C; Mussolin B; Cassingena A; Ponzetti A; Moran S; Siravegna G; Barault L; Amatu A;

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2016 Jun;17(6):738-746. doi: 10.1016/S1470-2045(16)00150-9. Epub 2016 Apr 20.

2016
AOU Città della Salute di Torino

Sartore-Bianchi A; Trusolino L; Martino C; Bencardino K; Lonardi S; Bergamo F; Zagonel V; Leone F; Depetris I; Martinelli E; Troiani T; Ciardiello F; Racca P; Bertotti A; Siravegna G; Torri V; Amatu A; Ghezzi S; Marrapese G; Palmeri L; Valtorta E; Cassingena A; Lauricella C; Vanzulli A; Regge D; Veronese S; Comoglio PM; Bardelli A; Marsoni S; et alii...

Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Sep;26(9):1994-1999. doi: 10.1093/annonc/mdv272. Epub 2015 Jun 25.

2015
AOU Città della Salute di Torino

Barault L; Amatu A; Bleeker FE; Moutinho C; Falcomatà C; Fiano V; Cassingena A; Siravegna G; Milione M; Cassoni P; De Braud F; Rudà R; Soffietti R; Venesio T; Bardelli A; Wesseling P; de Witt Hamer P; Pietrantonio F; Siena S; Esteller M; Sartore-Bianchi A; Di Nicolantonio F;

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. in Nature medicine / Nat Med. 2015 Jul;21(7):795-801. doi: 10.1038/nm.3870. Epub 2015 Jun 1.

2015
AOU Città della Salute di Torino

Siravegna G; Mussolin B; Buscarino M; Corti G; Cassingena A; Crisafulli G; Ponzetti A; Cremolini C; Amatu A; Lauricella C; Lamba S; Hobor S; Avallone A; Valtorta E; Rospo G; Medico E; Motta V; Antoniotti C; Tatangelo F; Bellosillo B; Veronese S; Budillon A; Montagut C; Racca P; Marsoni S; Falcone A; Corcoran RB; Di Nicolantonio F; Loupakis F; et alii...